Bleeding and Thrombotic Complications in COVID-19-Associated ARDS Requiring ECMO

Eduardo P Tavares1, José R Rebolo2, Rodrigo Pimentel2

  • 1Faculty of Medicine of Porto, Porto, Portugal.

Respiratory Care
|November 15, 2022
PubMed

Insights

Patients with COVID-19-associated Acute Respiratory Distress Syndrome (ARDS) requiring extracorporeal membrane oxygenation (ECMO) experienced more severe bleeding complications and longer treatment durations compared to other ARDS causes. Further research is needed to assess ECMO

Area of Science:

  • Critical Care Medicine
  • Pulmonology
  • Infectious Diseases

Background:

  • Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition.
  • Extracorporeal Membrane Oxygenation (ECMO) is a life support treatment for severe ARDS.
  • COVID-19 has been associated with a unique ARDS presentation.

Purpose of the Study:

  • To compare bleeding and thrombotic complications in COVID-19-associated ARDS versus other causes of ARDS requiring ECMO.
  • To analyze clinical outcomes and ECMO course in COVID-19 ARDS patients.

Main Methods:

  • A single-center observational study included adult patients undergoing ECMO for COVID-19 ARDS (n=67) or other ARDS (n=60).
  • Exclusion criteria included trauma patients.
  • Data on complications, laboratory values, and clinical outcomes were collected and compared.

Main Results:

  • COVID-19 ARDS patients had lower invasive mechanical ventilation duration before ECMO and less frequent ECMO retrieval.
  • Despite similar thrombotic complications and predicted survival scores, COVID-19 ARDS showed higher rates of severe bleeding (airway bleeding, hemothorax), lower hemoglobin, and increased red blood cell transfusions.
  • COVID-19 ARDS was associated with significantly longer ECMO duration (47 days vs 19 days) but no significant difference in in-hospital mortality.

Conclusions:

  • COVID-19-associated ARDS requiring ECMO is characterized by a high incidence of severe bleeding complications and prolonged treatment duration.
  • Further investigation is warranted to fully understand the risks and benefits of ECMO in severe COVID-19 ARDS.
  • Clinical management strategies may need to be adapted for COVID-19 ARDS patients on ECMO, particularly regarding bleeding risk.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
31
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
26
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
33
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
356
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
16